MedPath
NMPA Approval

利福昔明

国药准字H20070299

April 22, 2022

国药准字H20070299

Drug Information

利福昔明

原料药

化学药品

April 22, 2022

Company Information

Applicant Company

Manufacturing Company

扬州市江都区宜陵镇国泰路51号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福昔明 - NMPA 批准文号 | MedPath